{"uuid": "eddc7090-4433-605e-48b1-2831bf23d4c8", "code": "MVBS.02.013", "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2024-06-04T12:43:56", "title": {"en": "Drugs in Oncology - Drug Development, Clinical Trials and Use in Clinical Practice", "et": "Ravimid onkoloogias - nende arendus, olemus ja kasutamine kliinilises töös"}, "credits": 2, "general": {"input_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}], "structural_unit_shares": [{"structural_unit_code": "MVBS02", "structural_unit_name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "course_share_percent": 100, "coordinating": true}], "type": {"code": "regular", "et": "Tavaline aine", "en": "Regular course"}, "structural_units": [{"code": "MVBS02", "name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "phone": "+372 737 4350", "webpage_url": "https://biomeditsiin.ut.ee/et/sisu/farmakoloogia-osakond", "address": "EST", "level": 3, "academic": true, "supports_continuous_learning": false, "parent_code": "MVBS"}]}, "additional_info": {"duration_in_semesters": 1, "occurrence_frequency": {"code": "year", "et": "igal õppeaastal", "en": "every academic year"}, "assessment_scale": {"code": "pass", "et": "Eristamata (arv, m.arv, mi)", "en": "non-differentiated (pass, fail, not present)"}, "is_vota_course": true, "is_continuous_learning_course": false}, "overview": {"description": {"en": "This course has six three-hour sessions, each session has 1.5 h lecture and 1.5 h seminar with active contribution from participants.", "et": "Aine koosneb kuuest 3-tunnisest kohtumisest, millest 1,5 tundi on loeng ja ülejäänud 1,5 tundi seminar ning lisaks e-seminarist iseseisvas õppimiseks antud materjalide põhjal."}, "objectives": [{"en": "The aim of this course is to give an overview of new drug classes used in oncology, drug development and clinical trials in oncology and principles of systemic treatment of common solid tumours.", "et": "Aine eesmärgiks on anda ülevaade onkoloogias kasutavatest ravimrühmadest, ravimarendusest ja kliinilistest uuringutest ning kasutamisest erinevate pahaloomuliste kasvajate ravis."}], "learning_outcomes": [{"en": "1. Better understanding of drugs used in oncology", "et": "1. Süvendada teadmiseid onkoloogiliste ravimite osas"}, {"en": "2. Give an overview of systemic treatment in various malignant tumours and treatment related side effects", "et": "2. Tutvustada põhjalikumalt onkoloogiliste ravimite kasutamist erinevate pahaloomuliste kasvajate ravis, sh nende kõrvaltoimeid"}, {"en": "3. Increase an interest in drug development and clinical trials in oncology", "et": "3. Suurendada huvi onkoloogiliste ravimite arenduse ja kliiniliste uuringute vastu"}]}, "_actions": {"is_version_creatable": false, "is_editable": false, "is_deletable": false}}